<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>01581nam a2200301   4500</leader>
  <controlfield tag="001">ESSALUD</controlfield>
  <controlfield tag="005">20260804163623.0</controlfield>
  <controlfield tag="007">ta</controlfield>
  <controlfield tag="008">      t        pe ||||| |||| 00| 0 spa d</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">BMG</subfield>
  </datafield>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Williams, David A. </subfield>
    <subfield code="e">Autor</subfield>
    <subfield code="9">53761</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Fibromyalgia</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">p&#xE1;ginas: 267-277</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Fibromyalgia is characterized by widespread pain involving any body tissue and typically accompanied by fatigue and problems with sleep, mood, and memory. Fibromyalgia can occur alone or in combination with other chronic overlapping primary pain conditions, or it can be superimposed on other conditions, such as autoimmune disorders (secondary pain). In fibromyalgia, the central nervous system (CNS) is hyperresponsive to sensory stimuli generally. Successful pharmacologic and nonpharmacologic interventions focus on the CNS to support CNS quiescence and a return to homeostasis. Although fibromyalgia is rarely curable, most cases can be well managed in the context of primary care.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">MEDICINA DEL ADOLESCENTE</subfield>
    <subfield code="9">5533</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">MEDICINA CL&#xCD;NICA</subfield>
    <subfield code="9">33681</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">MEDICINA CL&#xCD;NICA AMBULATORIA</subfield>
    <subfield code="9">53762</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">ENFERMEDAD NEUROMUSCULAR</subfield>
    <subfield code="9">53763</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">ENDOCRINOLOG&#xCD;A </subfield>
    <subfield code="9">36891</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">NEUROLOG&#xCD;A</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">DOLOR</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">PEDIATR&#xCD;A</subfield>
    <subfield code="9">6401</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">PSIQUIATR&#xCD;A</subfield>
    <subfield code="9">5413</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Clauw, Daniel J. </subfield>
    <subfield code="9">53764</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
    <subfield code="0">22717</subfield>
    <subfield code="9">22636</subfield>
    <subfield code="d">Massachusetts NEJM Group</subfield>
    <subfield code="o">NEJM003</subfield>
    <subfield code="t">The New England Journal of Medicine </subfield>
    <subfield code="w">ESSALUD</subfield>
    <subfield code="x">0028-4793</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">ARTICULOS</subfield>
    <subfield code="e">2026-07-31</subfield>
    <subfield code="z">SQB</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">22740</subfield>
    <subfield code="d">22740</subfield>
  </datafield>
</record>
